000 | 01620 a2200517 4500 | ||
---|---|---|---|
005 | 20250514020219.0 | ||
264 | 0 | _c20020103 | |
008 | 200201s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSuh, N | |
245 | 0 | 0 |
_aArzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. _h[electronic resource] |
260 |
_bCancer research _cDec 2001 |
||
300 |
_a8412-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticarcinogenic Agents _xmetabolism |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEstradiol _xpharmacology |
650 | 0 | 4 |
_aEstradiol Congeners _xpharmacology |
650 | 0 | 4 |
_aEstrogen Antagonists _xmetabolism |
650 | 0 | 4 |
_aEthinyl Estradiol _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xpathology |
650 | 0 | 4 |
_aPiperidines _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Estrogen _xantagonists & inhibitors |
650 | 0 | 4 |
_aTamoxifen _xpharmacology |
650 | 0 | 4 |
_aThiophenes _xmetabolism |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aUterus _xdrug effects |
700 | 1 | _aGlasebrook, A L | |
700 | 1 | _aPalkowitz, A D | |
700 | 1 | _aBryant, H U | |
700 | 1 | _aBurris, L L | |
700 | 1 | _aStarling, J J | |
700 | 1 | _aPearce, H L | |
700 | 1 | _aWilliams, C | |
700 | 1 | _aPeer, C | |
700 | 1 | _aWang, Y | |
700 | 1 | _aSporn, M B | |
773 | 0 |
_tCancer research _gvol. 61 _gno. 23 _gp. 8412-5 |
|
999 |
_c11645168 _d11645168 |